Rossi, C., André, M., Dupuis, J., Morschhauser, F., Joly, B., Lazarovici, J., Ghesquières, H., Stamatoullas, A., Nicolas-Virelizier, E., Feugier, P., Gac, A.-C., Moatti, H., Fornecker, L.-M., Deau, B., Joubert, C., Fortpied, C., Raemaekers, J., Federico, M., Kanoun, S., Meignan, M., Traverse-Glehen, A., Cottereau, A.-S. and Casasnova, R.-O. (2022) “High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline”, Haematologica. Pavia, Italy, 107(12), pp. 2897-2904. doi: 10.3324/haematol.2021.280004.